Medication-Related Osteonecrosis of the Jaw: Bibliometric Analysis from 2003 to 2023.

4区 医学 Q2 Biochemistry, Genetics and Molecular Biology Advances in experimental medicine and biology Pub Date : 2024-07-30 DOI:10.1007/5584_2024_818
Ferit Bayram, Sabire Senem Kilic, Volkan Aydin, Ahmet Akici, Korkut Ulucan, Tunc Akkoc
{"title":"Medication-Related Osteonecrosis of the Jaw: Bibliometric Analysis from 2003 to 2023.","authors":"Ferit Bayram, Sabire Senem Kilic, Volkan Aydin, Ahmet Akici, Korkut Ulucan, Tunc Akkoc","doi":"10.1007/5584_2024_818","DOIUrl":null,"url":null,"abstract":"<p><p>Medication-related osteonecrosis of the jaw (MRONJ) is a serious condition associated with the use of antiresorptive and antiangiogenic medications. Despite extensive research, the pathophysiology of MRONJ remains poorly understood. Bibliometric analysis provides insights into the academic impact of research, helping identify influential works and emerging trends in this field. This study employed a bibliometric analysis of MRONJ publications indexed in Web of Science from 2003 to 2023. The analysis included English-language articles and utilized the VOSviewer, R Studio Bibliometrix package, and Graphpad to evaluate citation counts, publication trends, and collaboration patterns. This study unveils the current situation of the MRONJ research, addressing well-recognized safety issues of antiresorptive and antiangiogenic agents. Our findings may suggest that the overall trend of the MRONJ research continues to evolve and is not likely to reach its peak or plateau yet. We believe that our work will help to identify gaps in the literature and future research directions, contributing to a better understanding of MRONJ management.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in experimental medicine and biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/5584_2024_818","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a serious condition associated with the use of antiresorptive and antiangiogenic medications. Despite extensive research, the pathophysiology of MRONJ remains poorly understood. Bibliometric analysis provides insights into the academic impact of research, helping identify influential works and emerging trends in this field. This study employed a bibliometric analysis of MRONJ publications indexed in Web of Science from 2003 to 2023. The analysis included English-language articles and utilized the VOSviewer, R Studio Bibliometrix package, and Graphpad to evaluate citation counts, publication trends, and collaboration patterns. This study unveils the current situation of the MRONJ research, addressing well-recognized safety issues of antiresorptive and antiangiogenic agents. Our findings may suggest that the overall trend of the MRONJ research continues to evolve and is not likely to reach its peak or plateau yet. We believe that our work will help to identify gaps in the literature and future research directions, contributing to a better understanding of MRONJ management.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与药物相关的颌骨骨坏死:2003年至2023年的文献计量分析。
药物相关性颌骨坏死(MRONJ)是一种与使用抗骨质吸收和抗血管生成药物相关的严重疾病。尽管进行了大量研究,但人们对 MRONJ 的病理生理学仍然知之甚少。文献计量学分析可深入了解研究的学术影响力,有助于识别该领域有影响力的著作和新兴趋势。本研究采用文献计量学分析方法,对2003年至2023年Web of Science收录的MRONJ出版物进行了分析。分析包括英文文章,并利用 VOSviewer、R Studio Bibliometrix 软件包和 Graphpad 评估了引文数量、出版趋势和合作模式。本研究揭示了MRONJ研究的现状,探讨了公认的抗骨吸收剂和抗血管生成剂的安全性问题。我们的研究结果可能表明,MRONJ 研究的总体趋势仍在继续发展,还不可能达到顶峰或高原。我们相信,我们的工作将有助于找出文献中的空白和未来的研究方向,从而有助于更好地理解 MRONJ 的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advances in experimental medicine and biology
Advances in experimental medicine and biology 医学-医学:研究与实验
CiteScore
5.90
自引率
0.00%
发文量
465
审稿时长
2-4 weeks
期刊介绍: Advances in Experimental Medicine and Biology provides a platform for scientific contributions in the main disciplines of the biomedicine and the life sciences. This series publishes thematic volumes on contemporary research in the areas of microbiology, immunology, neurosciences, biochemistry, biomedical engineering, genetics, physiology, and cancer research. Covering emerging topics and techniques in basic and clinical science, it brings together clinicians and researchers from various fields.
期刊最新文献
Dietary Lipids and Their Metabolism in the Midgut. Insect Lipid Metabolism in the Presence of Symbiotic and Pathogenic Viruses and Bacteria. Amniotic Membrane Transplantation: Clinical Applications in Enhancing Wound Healing and Tissue Regeneration. Wnt/β-catenin Signaling in Central Nervous System Regeneration. Flavonoids as Chemosensitizers in Leukemias.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1